BIOTECH IN A Dr. KSS-LESS WORLDBIOTECH IN A Dr. KSS-LESS WORLD Welcome! The purpose of this thread will be to discuss, identify and follow small or mid-cap biotechs that have credible scientific platforms , big potential target markets, favorable qualified second party medical opinion, and significant stock appreciation potential in a one-to-three year time horizon; and to create and track […]
Articles
- Most Relevant
- Most Recent
Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]
[Ed. Note: Dr. KSS is our biotech and medical maven, who writes for the Irregulars. He has agreed to our trading restrictions, chooses is own topics, and his words and opinions are his own. You can find all of his previous articles and most recent comments on his Stock Gumshoe page.] Although the drive to […]
This thread is designed to allow investors to discuss the nature, strategies, tactics and stocks content of Bio ETF’s. Before getting too engrossed in detail, please think about how we can create a structure for how to do this. I will publish a list of ALL known ETF’s. No one person could handle all the […]
This thread is designed to allow Irregulars to discuss, share and provide input for calender catalyst events, primarily but not limited to equities contained on the Green Tab of the KSS Da Man! spreadsheet that is maintained by Hi Pockets. The calender currently can be updated only by Benny, Lawrence, Dr. KSS and myself. The […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for our Irregulars. He chooses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Visit his Stock Gumshoe page for more.] Bacteria are prokaryotes. Animal cells, fungi and plants are eukaryotes. Prokaryotes tend to be acellular and […]
We need a method for retaining and organizing information about the Biotech tickers discussed here in the lofty retreat of the Gumshoe library. DLH and I are considering starting a Google Doc file (or files) for keeping notes about each biotech ticker discussed fior both KSS opinions and others. . My initial thinking (DLH has […]
We will no longer be publishing the commentary of Dr. KSS, who wrote about biotech stocks for the Irregulars for several years. Late last week, he decided to move on and resign from his work here. I imagine he will likely start his own publication of some sort in the future — all I know […]
There’s a pitch to invest in what the author calls a 26(f) program. The authors encourages participation before April 10, 2017, when the Federal Government will declare a ”RETIREMENT BLACKOUT”. Investing in this type of fund supposedly out performs any other retirement fund. What can this be? It’s copy righted by Money Map Press.
[Ed. Note: Dr. KSS writes about medicine biotech stocks for the Gumshoe Irregulars. He chooses his own topics, and his words and opinions are his own. Visit his Stock Gumshoe page for his past articles and most recent comments.] Assessing biotechnology stocks involves use of lots of mental microscopes and magnifying lenses. But the task […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] His tidily rhyming names perhaps destined him for fame. While Jack Kerouac’s work and popularity were before my time, his cultural and literary restlessness assure him […]
A pre-emptive tease: no newsletters are yet touting this company, but like many stocks that they do tease, it is small, cheap, almost unknown, and even has the exotic appeal of being Australian. Sort of. At Stock Gumshoe we not only deconstruct pitched stocks, we find teasable stocks before the newsletters do! Let’s return to […]
This discussion came about as the result of the GS thread ”This Tiny, Unknown Biotech is About to Unleash Its ‘Holy Grail’ Drug” It is hoped that all/any that can throw light, can brainstorm here and feedback consensus to the thread. Good work Guys. my best Alan Harris.
Robert Morris is helming a biotech-focused stock newsletter that’s called Biotech Supertrader (modesty has no place in the world of newsletter promotions, of course), and I’ve never covered this letter before so I thought I ought to have a look at the latest teaser we’ve been asked about. Morris, incidentally, has been featured in our […]
Or perhaps a better title would have been, “Pruning during a forest fire.” As the markets go through wild swings (no, that’s not right — swings move both ways — I mean “wild drops”), I feel as I often do at times like these: That I wish I had more cash to invest. I’d never […]
Monthly newsletter on biotech stocks with weekly updates.
This note should not be considered to indicate my opinions on any of the stocks herein, or to be any kind of market prognostication about the months ahead (I’m personally worried about the market this fall, but I rarely trade on such short term worries). But since I’ve promised to disclose my portfolio to you, […]
Launched by the Gardner brothers, with one stock pick from each per issue, but now Tom and David Gardner have largely stepped back from stock picking and the picks are made by “Rule Breaker” and “Everlasting Stock” teams.
If you happen to follow any of the stocks I own, you might have noticed two big movers lately, in opposite directions — Exelixis moving up, and ABB Grain moving down. In my opinion, neither one has huge implications, but both of these moves are because the company is raising money for future projects. In […]
Recent Comments
Thanks DD!! PTLB ? did you mean PRLB ? exellent picks !...
oldladyinvestor Exellent Job, very highly apreciated! Many thanks...
Saw this in my inbox today and hoped it was CPNG which I bought today for the long haul. Thanks for the great analysis....
True Momentum — Trade Alert: Sell EXEL for Profits...
i really get pleasure reading the reports also matt carr viper alert is dynamite i need to know how to ask him a question about options how do i reach…...
TM- current portfolio 10/21/2020 znga,swch, qlys, prlb, mtls, irbt, box, form, entg, upwk, cree, sedg, enph, powi, vicr, srpt, nvcr, exel, arna, uthr, nbix, neo, gh, and ntra with irbt…...
$PTLA Names Scott Garland President and CEO effective October 8. Formerly Relypsa president and $EXEL CCO https://twitter.com/odibro/status/1042753469483024384 thx Best...
$GILD - And EndPoints from John Carroll TOP STORIES Searching for HIV cure, Gilead's new 'shock and kill' combo swats back lethal virus in monkeys Faster, more convenient Opdivo dosing…...
Lots of good info from EndPoints: NEW Judgment day is coming: Federal judge orders Martin Shkreli to forfeit a small fortune following felony convictions → Endpoints News Global CRO Parexel…...
I have owned $EXEL for years. It is regularly talked up on another investment site. People with real credentials in science, medicine, and finance are convinced EXEL is the real…...
I thought angiogenesis was old news and has been largely discredited. However EXEL does have a good looking pipeline and is considered a buyout candidate this year. At an $8.6…...
Global Investing's biotech maven tipped this one on our pages and I am a happy camper in EXEL despite it being a US stock....
Goldman: Setting the stage for oncology M&A in 2018 Tax reform unlocks ~$160bn ex-US cash for potential M&A Potential top 5 acquirers: $CELG, $PFE, $GILD, $MRK, $JNJ ...expect the M&A…...
no you dedicate a small portion of your portfolio and only buy stocks you want to hold for a week. you buy the stock sell the calls each week. i…...
$MOTELY Fool's top 4 BIO Pics for 2018. Just got a teaser ad for the MF Explorer investment newsletter. They are nominating what they think are the 4 top pics…...
I joined Supernova two years ago to better manage my 401K. I am in the Odyssey 2 portfolio, which has done reasonably well, close to matching the S&P 500. They…...
I bought $EXEL a few years ago for $11 and change left it alone unil they had a viable product, just sold it when it hit $30. The lesson I…...
$capr dmd. Poster link MIA. 6mo PUL MIA. https://twitter.com/XsleepftLearner/status/915540626602590208 $CNCR Loncar Cancer Immunotherapy Index Announchttps://twitter.com/odibro/status/915551131455180800 es Merger Replacements. $GILD $NLNK added replacing $KITE $AMGN IN $MBOT #ArtificialIntelligence The robot boom…...
Some of the companies at the Cantor Fitzgerald Conference this week. Many are also presenting at the Landenburg Thalmann Conference, also this week. AcelRx Pharmaceuticals Inc. (ACRX) Achaogen Inc. (AKAO)…...
$FYI New Battery That Could Be Charged in Seconds Developed at Drexel University https://www.inc.com/yoram-solomon/a-drexel-university-discovery-could-be-the-tipping.html This new material Mxene is specifically, again it appears to replace cobalt, it is nano technology…...
$ AFMD long From Briefing.com Exelixis (EXEL) initiated with Buy and $33 tgt, Affimed Therapeutics (AFMD) with Buy and $7 tgt and Editas Medicine (EDIT) with a Hold and $17…...
$EXEL Doc, thanks for your summation. If you expect failure in the HCC trial that's reason enough for me not to pull the trigger. I appreciate your quick response....
I'll have a crack at it. It's hard to justify covering, and logging research hours poking into, companies where we see no profit to be made, and I feel that's…...
$EXEL,$BMY Exelixis and Bristol-Myers are two companies that have gotten relatively scant attention here over the years. The two fims announced the launch of a P3 trial called Checkmate 9ER…...
$APTO long Mr Lytten is quite active in biotech in his own name and the AWL Family Office LLC. Tried to figure out who he is and all I could…...
$No ticker. Lumpified, I have 27 biotechs. Seems as if the trend is up. Recently sold out of EXEL and mostly out of INCY. Planning to add a lot more…...
$AUPH: My hometown is Melbourne, maybe I should go on a reconnaissance mission as an attaché-for the Gummune. Do you need medical accreditation to attend? If my memory serves me…...
Ophad Hammer blog on $ESPR, $TRVN,$EXEL, $ARGL. Very long ESPR, long EXEL http://www.orf-blog.com/biotech-portfolio-updates-esperion-trevena-exelixis-and-arqule/...
A contribution to the recent and well recognized choir song surrounding Gilead by me here. I simply couldn't resist after finally getting round to listening to their most recent earnings…...
$EXEL #RCC $EXEL and Takeda Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Japan Business Wire January 30, 2017 SOUTH SAN FRANCISCO, Calif. &…...
Long $ABIO $AGEN $AMGN $APTO $ARGS $ARTH $AUPH $BIOC $CELG $CUR $CYDY $ENUM $ESPR $EXEL $GBT $GILD $ILMN $INCY $JAZZ $LMAT $MYL $NVTA $PARN $PIRS $PTLA $PTN $REGN $REPH $RGLS…...
Below is an interesting blog article - another affirmation and salutation to Dr. KSS's biotech vision: "2016 Biotech Superstars. $AKAO $EXEL $CLCD $CRBP" http://www.precisiontrade365.com/biotechs-superstar-in-2016-akao-exel-clcd-crbp-12-30-16/ All but $EXEL were the subject…...
6 Best Biotech Stocks Of 2016 as viewed by #Benzinga - $CRBP $CLCD $EXEL $TSRO $AKAO $PIP (See details in article) http://www.benzinga.com/general/biotech/16/12/8832003/6-best-biotech-stocks-of-2016 Of the six tickers from the list, Doc…...
$TSRO yes. I admit Tesaro kind of caught me napping. The problem is PARP inhibitors, which Tesaro has. There have been SO MANY of them to fail, I presumed it…...
Agree Doc! i like $TSRO more than $INCY or $EXEL. All the three are good takeover candidates apart from our fav $AKAO after P3 success!...
$ESPR Esperion – Another overhang removed Esperion (ESPR) reported yet another data set that showed its drug, bempedoic acid (ETC-1002), leads to reduction in LDL-C and CRP. The study, which…...
@ACElecConnect @Exelon No lights.No fridge No phone No heatNo stove No wifi No jobNo medicine @KateLew94501987 @twittmanda via https://twitter.com/nma08244/status/792316172813336576 https://pbs.twimg.com/media/Cv7fWx0WcAA9sZI.jpg...
Exelixis (EXEL) Cabozantinib bests Sunitinib for mRCC (kidney cancers) . http://www.onclive.com/conference-coverage/esmo-2016-congress/frontline-cabozantinib-bests-sunitinib-in-mrcc http://www.investopedia.com/news/exelixis-finds-success-cabozantinib-exel/?partner=YahooSA&yptr=yahoo Cheers,Glenn...
Oct2016 : $BLUE $SCYX $PRQR $PTN $PTI $ESPR $ARWR $ADAP $CLDX $KPTI $EXEL $RPRX $OCRX $AKAO $CNAT $IDRA $RGLS $VCEL $XXII $CASC $EGLT #BIOS via @SheffStation...
$BPMC, a leading player in the kinase inhibitors field as applied to oncology, and one that Dr. KSS spoke favorably about in the past, made an important announcement today. Market…...
Exelixis, Ipsen Say European Commission Approves Kidney Cancer Drug 8:17 am ET (Dow Jones)...
$EXEL Don't want to steal your time - but do you have a quick opinion about exelixis and its recent mighty run? Haven't found any content about this stock, so…...
$EXEL - From SA: http://seekingalpha.com/news/3187291-exelixis-cabometyx-superior-novartis-afinitor-extending-survival-kidney-cancer-patients-late?source=email_rt_mc_readmore&uprof=44&dr=1#email_link Long $EXEL jokin...
Re: EXEL from SA: http://seekingalpha.com/news/3187279-exelixis-ipsen-announce-phase-3-trial-results-cabometyx-tablets-demonstrating-significant?source=email_rt_mc_readmore&uprof=44&dr=1#email_link No position in $EXEL. jokin...
Feb2016 BeatDown Bios: $CBAY $CPXX $CPRX $PIRS $SYN $ONTY $ATNM $AVEO $CTIC $CRBP $IMNP $BCLI $SPHS $VSTM $PLX $CERU $CNAT $APRI $RTTR $NEOT March2016 Beaten Bios:$ONTY $CBAY $CPXX $CPRX $PIRS…...
Dressed to Kill: Tailoring a Suit For Tumor-Penetrating Cancer Meds - See more at: http://drexel.edu/now/archive/2016/April/enzyme-nanoparticles/#sthash.Z7sFDMM9.dpuf Tailoring a Suit For Tumor-Penetrating #Cancer Meds / drug-delivery @DrexelNews #nanotech pic.twitter.com/L7zMFV8DtP via BigFutureList (@bigfuturelist)...
CELG, EXEL- https://www.tipranks.com/analysts/john-sonnier?ref=expertalert Free or premium software to assist in DD prior to writing the cheque as alanh says. Best2All-Ben...
Dramatic Changes on Horizon in Renal Cell Carcinoma - BMY, EXEL (thanks Helen) See more at: http://www.onclive.com/web-exclusives/dramatic-changes-on-horizon-in-renal-cell-carcinoma#sthash.wzykX1W0.dpuf Best2All-Ben...
Here is you a list of threads that EXEL was discussed in at stockgumshoe: http://www.stockgumshoe.com/?s=EXEL&submit=Search and a free or relatively inexpensive investor tool: https://www.tipranks.com/stocks/exel Geaux Gummies! Best2You-Ben...
Thank you for the information. I do not own any $EXEL now, but did, and was wondering if would be a good repurchase. I am long $BPMC. So, double thanks.…...